(Q43155089)

English

Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults

scientific article published on 19 February 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Tae H Han

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Rebecca L Blanchard

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

John Palcza

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Jacqueline B McCrea

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Tine Laethem

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Kenneth Willson

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Yang Xu

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Susan Ermlich

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Janet Boyle

9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Christopher Lines

10

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Maria Gutierrez

11

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Luc Van Bortel

12

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Alan J Xiao

13

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Simon Sinclair

14

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Lisa Hickey

15

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Deborah Panebianco

16

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

M Gail Murphy

17

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1367-1376

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

The global burden of headache: a documentation of headache prevalence and disability worldwide

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

The epidemiology, burden, and comorbidities of migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Clinical and preclinical rationale for CGRP-receptor antagonists in the treatment of migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

New therapeutic target in primary headaches - blocking theCGRP receptor

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Potent, orally bioavailable calcitonin gene-related peptide receptor antagonists for the treatment of migraine: discovery of N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-relate

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Randomized, controlled trial of telcagepant for the acute treatment of migraine

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Elimination of diastereomer interference to determine Telcagepant (MK-0974) in human plasma using on-line turbulent-flow technology and off-line solid-phase extraction coupled with liquid chromatography/tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1177%2F0091270010361741

21 January 2018

Identifiers

10.1177/0091270010361741

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43155089&oldid=2143766980"